Utah Medical Products Inc
Utah Medical Products, Inc. provides medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company also provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal … Read more
Utah Medical Products Inc (UTMD) - Total Assets
Latest total assets as of December 2025: $122.54 Million USD
Based on the latest financial reports, Utah Medical Products Inc (UTMD) holds total assets worth $122.54 Million USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Utah Medical Products Inc - Total Assets Trend (1987–2025)
This chart illustrates how Utah Medical Products Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Utah Medical Products Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Utah Medical Products Inc's total assets of $122.54 Million consist of 79.8% current assets and 20.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 70.0% |
| Accounts Receivable | $3.52 Million | 2.9% |
| Inventory | $7.93 Million | 6.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $14.89 Million | 12.2% |
Asset Composition Trend (1987–2025)
This chart illustrates how Utah Medical Products Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Utah Medical Products Inc's current assets represent 79.8% of total assets in 2025, an increase from 61.6% in 1987.
- Cash Position: Cash and equivalents constituted 70.0% of total assets in 2025, up from 23.3% in 1987.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 2.0% in 1987.
- Asset Diversification: The largest asset category is goodwill at 12.2% of total assets.
Utah Medical Products Inc Competitors by Total Assets
Key competitors of Utah Medical Products Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Utah Medical Products Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Utah Medical Products Inc generates 0.31x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Utah Medical Products Inc generates $9.21 in net profit.
Utah Medical Products Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 37.62 | 25.64 | 14.59 |
| Quick Ratio | 34.57 | 23.29 | 13.28 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $95.14 Million | $ 92.57 Million | $ 62.05 Million |
Utah Medical Products Inc - Advanced Valuation Insights
This section examines the relationship between Utah Medical Products Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.71 |
| Latest Market Cap to Assets Ratio | 1.44 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | $122.54 Million |
| Market Capitalization | $177.03 Million USD |
Valuation Analysis
Above Book Valuation: The market values Utah Medical Products Inc's assets above their book value (1.44 x), reflecting positive investor sentiment about the company's future prospects.
Slight Asset Contraction: Utah Medical Products Inc's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Utah Medical Products Inc (1987–2025)
The table below shows the annual total assets of Utah Medical Products Inc from 1987 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $122.54 Million | +0.00% |
| 2024-12-31 | $122.54 Million | -9.54% |
| 2023-12-31 | $135.46 Million | +9.35% |
| 2022-12-31 | $123.87 Million | +7.12% |
| 2021-12-31 | $115.64 Million | +3.48% |
| 2020-12-31 | $111.75 Million | +1.78% |
| 2019-12-31 | $109.79 Million | +10.04% |
| 2018-12-31 | $99.77 Million | +7.57% |
| 2017-12-31 | $92.75 Million | +21.10% |
| 2016-12-31 | $76.58 Million | -3.27% |
| 2015-12-31 | $79.17 Million | -2.34% |
| 2014-12-31 | $81.08 Million | +0.45% |
| 2013-12-31 | $80.71 Million | +4.91% |
| 2012-12-31 | $76.94 Million | +0.71% |
| 2011-12-31 | $76.39 Million | +85.24% |
| 2010-12-31 | $41.24 Million | -1.24% |
| 2009-12-31 | $41.75 Million | +7.56% |
| 2008-12-31 | $38.82 Million | -15.58% |
| 2007-12-31 | $45.99 Million | +4.07% |
| 2006-12-31 | $44.19 Million | +6.11% |
| 2005-12-31 | $41.64 Million | +0.92% |
| 2004-12-31 | $41.26 Million | -16.97% |
| 2003-12-31 | $49.69 Million | +112.49% |
| 2002-12-31 | $23.39 Million | -0.78% |
| 2001-12-31 | $23.57 Million | -7.28% |
| 2000-12-31 | $25.42 Million | -8.41% |
| 1999-12-31 | $27.76 Million | -13.26% |
| 1998-12-31 | $32.00 Million | +1.59% |
| 1997-12-31 | $31.50 Million | +9.00% |
| 1996-12-31 | $28.90 Million | -13.21% |
| 1995-12-31 | $33.30 Million | +21.53% |
| 1994-12-31 | $27.40 Million | -3.18% |
| 1993-12-31 | $28.30 Million | +1.07% |
| 1992-12-31 | $28.00 Million | +30.84% |
| 1991-12-31 | $21.40 Million | +37.18% |
| 1990-12-31 | $15.60 Million | +31.09% |
| 1989-12-31 | $11.90 Million | +20.20% |
| 1988-12-31 | $9.90 Million | +35.62% |
| 1987-12-31 | $7.30 Million | -- |